superagi_logo
Simon Michel

Simon Michel

linkedin_icon
Nationalrat @ The Federal Assembly — The Swiss Parliament CEO and Member of the Board at Ypsomed Group and Member of the Swiss National Council
email_icon
Email encrypt_section
call_icon
Phone Number encrypt_section

Education

education_icon_placeholder

University of St.Gallen

Master, Media- and Communications Management 1997-01-01 - 2003-01-01
education_icon_placeholder

Lancaster University

, Entrepreneurship 2000-01-01 - 2000-01-01

Work Experience

experience_icon_placeholder

The Federal Assembly — The Swiss Parliament

Current

The Federal Assembly — The Swiss Parliament

experience_icon_placeholder

Ypsomed AG

Current

Ypsomed AG

experience_icon_placeholder

Kanton Solothurn

2016-05-01 - 2024-02-01

Kanton Solothurn

experience_icon_placeholder

Orange Communications SA

2003-08-01 - 2006-06-01

Orange Communications SA

experience_icon_placeholder

Arthur D. Little

2002-06-01 - 2002-09-01

Arthur D. Little

experience_icon_placeholder

Disetronic Medical Systems, Inc.

2000-03-01 - 2000-07-01

Disetronic Medical Systems, Inc.

Skills

Cross-functional Team Leadership Business Strategy Medical Devices New Business Development Market Development Diabetes Strategic Planning Management

Summary

Ypsomed Group (SIX: YPSN) is the leading developer and manufacturer of self-injection systems focusing on the treatment of chronic diseases such as diabetes, obesity, polyarthritis, Alzheimer, migraine and many more. Headquarter in Switzerland with manufacturing sites in Switzerland, Germany, Czech Republic and China. http://www.ypsomed.com

Browse SuperAGI Directories
agi_contact_icon
People Search
1 2 3 4 5 ... 22732309
agi_company_icon
Company Search
1 2 3 4 5 ... 809223
AI Native CRM for Unified Sales, Support & Marketing Accelerate growth and streamline your entire stack with AI CRM Platform